Inhibition of the MEK/ERK Signaling Pathway Enhances Erythroid Differentiation but Reduces the Engraftment Potential of Ex Vivo Expanded Hematopoietic Stem Cells
Examining the role of the MEK/ERK pathway in umbilical cord blood stem cells shows that inhibiting this pathway reduces cell proliferation while enhancing their differentiation into red blood cells—an important finding for regenerative medicine and the treatment of blood disorders.




